Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Peter Callegari"'
Publikováno v:
Clinical Therapeutics. 30:1375-1384
Anti-tumor necrosis factor (TNF) biologic agents are effective in treating rheumatoid arthritis (RA). Information on patient persistence with biologic anti-TNF therapies is limited, and the effects of persistence on the costs of therapy are unknown.T
Autor:
Jeffrey R. Lisse, W. David Craig, Lesley Castro, Lisa Hymson, John L Harshbarger, Joseph E Huffstutter, Keith Gilmer, Newman Yeilding, David E. Yocum, Gregory Schimizzi, Shelley Kasle, Peter Callegari, Ronald Hegedus
Publikováno v:
Current Medical Research and Opinion. 23:1967-1979
To examine the impact of an electronic data capture system on patient satisfaction and patient-physician interactions in a rheumatology clinical setting.In this multicenter study, 1079 patients with rheumatoid arthritis completed questionnaires quart
Autor:
Anja Geldhof, Kezhen L. Tang, Salvatore Cucchiara, Subra Kugathasan, William A. Faubion, Richard A. Wright, Frank M. Ruemmele, Peter Callegari, Jeffrey S. Hyams, Benjamin D. Gold, Robert N. Baldassano, Gigi Veereman, James Markowitz, Marla Dubinsky, Anne M. Griffiths, Sibylle Koletzko, Mark R. Molenda, Harland S. Winter, John Fell, Johanna C. Escher, Richard B. Colletti
Publikováno v:
Gastroenterology. 144:S-147
matched controls without IBD. Information including diagnosis, IBD type, IBD activity, IBD medications, proton pump inhibitor (PPI) use, hospitalizations and antibiotic use was recorded. Patients were followed with repeat fecal and serum samples obta
Autor:
Kezhen L. Tang, Frank M. Ruemmele, William A. Faubion, Richard A. Wright, Peter Callegari, Marla Dubinsky, Mark R. Molenda, James Markowitz, John Fell, Robert N. Baldassano, Anne M. Griffiths, Richard B. Colletti, Anja Geldhof, Subra Kugathasan, Johanna C. Escher, Benjamin D. Gold, Sibylle Koletzko, Gigi Veereman, Harland S. Winter, Salvatore Cucchiara, Jeffrey S. Hyams
Publikováno v:
Gastroenterology. 144:S-11
all pts with PSC-IBD who underwent LT for non-cholangiocarcinoma indications at Mayo Clinic, Rochester from 1998-2008, with follow-up through 2012. Information on course of pre-transplant IBD, de novo IBD and colectomy was extracted. Progression of I
Autor:
Joseph Huffstutter, W. David Craig, Gregory Schimizzi, John Harshbarger, Jeffrey Lisse, Shelley Kasle, Lisa Hymson, David Yocum, Lesley Castro, Ronald Hegedus, Peter Callegari, Newman Yeilding, Keith Gilmer
Publikováno v:
Current Medical Research & Opinion; Aug2007, Vol. 23 Issue 8, p1967-1979, 13p